The Russian health ministry has informed that the country has produced the first batch of its new vaccine for COVID-19, reported Interfax news agency.
Russia has said the vaccine, the first for the coronavirus to go into production, will be rolled out by the end of this month.
Its approval comes before trials that would normally involve thousands of participants, commonly known as Phase III. Such trials are usually considered essential precursors for a vaccine to secure regulatory approval.
Also read: India’s first Covid vaccine is safe: preliminary results suggest
The vaccine has been named “Sputnik V” in homage to the world’s first satellite launched by the Soviet Union. President Vladimir Putin has assured the public that it is safe, adding that one of his daughters had taken it as a volunteer and felt good afterwards.
Moscow’s Gamaleya Institute, which developed the vaccine, said previously that Russia would be producing about five million doses a month by December-January, Interfax said.
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
